marcus evans europe conferences

8th Annual Biologics Formulation Development and Drug Delivery Forum

Foster the Stability and the Robustness of your Formulation Through all the Processes to Ensure a Safe Delivery to Patients

14-16 June 2017
Mövenpick Hotel, Berlin, Germany

Conference Workshop

Automation in Formulation Development: Boost the Quality and Efficiency of the Formulation

Workshop Moderator: Vanessa Jully, R&D Scientist, Head Preclinical,HTS & Discovery & Ahmad Sediq, Scientist Formulation Development

Company: GSK & Janssen

Why You Should Attend

8th Annual Biologics Formulation Development and Drug Delivery Forum

Optimising protein formulation stages has become a highly important area for the pharmaceutical industry. Formulation scientists still face large challenges in getting a stable, potent and safe product, mainly considering aggregation concerns, particle detection, bioavailability and immunogenicity. On the whole process also, formulation scientists need to get a clearer view from pre-formulation phase up to manufacturing and drug delivery, as influence of final result impact largely the way formulation is developed.

This marcus evans forum will discuss key challenges in biologics development, confronting formulation scientists and assist them with a better experiment protocol to ensure quality processes, efficient methodology and minimise failure risks. The delegates will benefit from experienced case study and understand how to improve formulation stability, preventing aggregation, develop high-concentration forms; they will also learn how to use predictive and analytical methods in order to understand the behaviour and evolution of proteins under different conditions, help scientists characterising proteins and different components of the formulation. They will also apprehend the manufacturing and scale up challenges, looking at compatibility problems, lyophilisation issues, and consider the different possibilities offered for drug delivery, keeping in mind the crucial need for improving comfort and safety to patient.

Key Topics

  • Improve the design of biological formulation with automated and highthroughput solutions
  • Integrate QbD processes in biological drug development
  • Enhance stability process controlling aggregation
  • Improve characterization with efficient analytical tools
  • Discuss the regulatory environment around biological drug development
  • Previous Attendees Include

    • GlaxoSmithKline • Pfizer • Abbvie • Roche Biologics • UCB • Sandoz • Abbott • Baxter • Novartis Vaccines • Sanofi aventis • Boehringer Ingelheim • Medimmune • Bayer • Bristol-Myers Squibb • Genentech • Janssen Pharmaceutical • Merck & Co • Novo Nordisk • University of Cambridge

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Unchained Labs
    Visit website >>

    Event Partners

    Practical Insights From

    Olivier Brass
    Senior Scientist
    Sanofi Pasteur

    Carsten Worsĝe
    Principal Scientist
    Novo Nordisk

    Manmohan Singh
    Senior Director, Drug Product Development
    Takeda Vaccines

    Benjamin Werner
    Research Assistant
    LMU München

    Ahmad Sediq
    Scientist Formulation Development

    Vanessa Jully
    R&D Scientist, Head Preclinical, HTS & Discovery

    Tanvir Tabish
    Head of Drug Product Development for Gene Therapy and Coagulation Factors

    Dimitrios Lamprou
    Associate Professor in Pharmaceutics & Drug Delivery
    University of Kent

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference was very interesting – all the topics presented have been very useful!”, Genzyme
    • “Really enjoyed the speakers & interactivity of the event!”, Ipsen
    • “One of the best meetings I’ve attended. Excellent organisation, topics and speakers”, GSK
    • “High quality agenda and fantastic speakers, I would definitely attend again”, Roche
    Latest Conference News & Resources

    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori

    PO Box 24797
    CY-1304 Nicosia

    +357 22 849 308
    Fax: +357 22 849 394